Press Release

Press Release
Interius’ Senior Director of Analytical Development to Speak at 14th Annual Bioprocessing Summit
November 01, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Press Release
Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
December 09, 2021

Company also celebrates “Deal of the Year” awarded by The Penn Center for Innovation PHILADELPHIA,…

read more
Press Release
Pennovation Lab Welcomes New Tenant Interius BioTherapeutics to Its Innovation Ecosystem
October 05, 2021
read more
Press Release
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
May 18, 2021

Interius BioTherapeutics, a preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery, today announced that it has raised $76 million in an oversubscribed Series A financing.

read more